Charles Schwab Investment Management Inc. Has $22.17 Million Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Charles Schwab Investment Management Inc. raised its holdings in Privia Health Group, Inc. (NASDAQ:PRVA) by 6.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,133,873 shares of the company’s stock after buying an additional 69,649 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.94% of Privia Health Group worth $22,167,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in PRVA. Riverbridge Partners LLC grew its holdings in Privia Health Group by 19.7% in the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock valued at $113,868,000 after buying an additional 958,418 shares during the last quarter. Eventide Asset Management LLC increased its position in shares of Privia Health Group by 979.2% during the third quarter. Eventide Asset Management LLC now owns 822,438 shares of the company’s stock valued at $14,977,000 after purchasing an additional 746,231 shares during the period. Icon Wealth Advisors LLC increased its position in shares of Privia Health Group by 1,910.1% during the third quarter. Icon Wealth Advisors LLC now owns 300,889 shares of the company’s stock valued at $5,479,000 after purchasing an additional 285,920 shares during the period. FMR LLC increased its position in shares of Privia Health Group by 1.5% during the third quarter. FMR LLC now owns 18,169,043 shares of the company’s stock valued at $330,858,000 after purchasing an additional 271,645 shares during the period. Finally, Barclays PLC increased its position in shares of Privia Health Group by 240.3% during the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock valued at $4,079,000 after purchasing an additional 158,188 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Stock Performance

Privia Health Group stock opened at $23.62 on Wednesday. The firm has a market cap of $2.85 billion, a P/E ratio of 236.22, a P/E/G ratio of 3.47 and a beta of 0.85. The business’s fifty day moving average is $23.49 and its two-hundred day moving average is $20.96. Privia Health Group, Inc. has a 52 week low of $15.92 and a 52 week high of $26.04.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Needham & Company LLC boosted their price objective on Privia Health Group from $25.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, February 28th. Stephens restated an “overweight” rating and set a $26.00 price objective on shares of Privia Health Group in a research report on Thursday, January 2nd. JMP Securities set a $29.00 price objective on Privia Health Group in a research report on Friday, February 28th. Piper Sandler boosted their price objective on Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a research report on Friday, February 28th. Finally, Macquarie assumed coverage on Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 price objective on the stock. One analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $26.67.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.